Tiziana life sciences ltd. granted 180-day extension by nasdaq to meet minimum bid price requirements

New york, dec. 14, 2022 (globe newswire) -- tiziana life sciences ltd. (nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company enabling breakthrough cns immunomodulation approaches to enhance the functionality of treg-based therapies, announced that it has received a notification letter from nasdaq stock market llc that the company has been granted an additional 180-day compliance period, with a new deadline of june 12, 2023, to regain compliance with nasdaq's minimum bid price rule.
TLSA Ratings Summary
TLSA Quant Ranking